Concordare Trials

Private

Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://concordare.com/

Last Round

Accelerator

Mar 9, 2026

Total Funding Raised

$320,000

Company Overview

Concordare Trials is a healthcare software company that develops a universal digital protocol to standardize clinical trial setup across software systems.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

protocol automationclinical trial automationdigital protocolclinical trial softwareAI for clinical trialseClinical solutionssite activationmachine-readable protocolClinical Protocol Template ModelCPTMcontract research organizationCROclinical operations softwarehealth techVertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concordare Trials Comps

Public and private peers based on sector, stage, and business model.

Concordare Trials comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Concordare Trials Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Mar 9, 2026
Accelerator	Feb 10, 2026

View all Funding Rounds

Concordare Trials Investors

Notable investors and investment history

Concordare Trials investors
Investor	Rounds
Techstars	Accelerator
AlphaLab	Accelerator
Innovation Works	Accelerator

View all Investors

Concordare Trials Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Concordare Trials Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concordare Trials's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania

Year Founded2024

Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.